Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- AI Summary
- About
Mirion Technologies Inc (MIR)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- Pass (Skip investing)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
01/29/2025: MIR (4-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit 0.94% | Avg. Invested days 31 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance 3.0 | Stock Returns Performance 1.0 |
Profits based on simulation | Last Close 01/29/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 3.68B USD | Price to earnings Ratio - | 1Y Target Price 19.2 |
Price to earnings Ratio - | 1Y Target Price 19.2 | ||
Volume (30-day avg) 2015786 | Beta 0.73 | 52 Weeks Range 9.11 - 18.81 | Updated Date 02/2/2025 |
52 Weeks Range 9.11 - 18.81 | Updated Date 02/2/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.32 |
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-02-11 | When Before Market | Estimate - | Actual - |
Profitability
Profit Margin -7.92% | Operating Margin (TTM) 0.1% |
Management Effectiveness
Return on Assets (TTM) 0.3% | Return on Equity (TTM) -4.3% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 4260252001 | Price to Sales(TTM) 4.4 |
Enterprise Value 4260252001 | Price to Sales(TTM) 4.4 | ||
Enterprise Value to Revenue 5.09 | Enterprise Value to EBITDA 28.65 | Shares Outstanding 225500000 | Shares Floating 154587045 |
Shares Outstanding 225500000 | Shares Floating 154587045 | ||
Percent Insiders 2.36 | Percent Institutions 96.29 |
AI Summary
Mirion Technologies Inc. Stock Analysis
Company Profile
History and Background: Mirion Technologies Inc. (formerly known as Canberra Industries Inc.) was founded in 1974. The company evolved from the acquisition of various businesses in the nuclear and scientific industries over the years. In 2021, Mirion Technologies was acquired by Advent International, a private equity firm, in a deal valued at $2.4 billion.
Core Business Areas: Mirion Technologies is a leading provider of nuclear detection and measurement solutions for a range of industries, including:
- Nuclear Power: Mirion supplies dosimetry, radiation monitoring, and contamination control solutions for nuclear power plants.
- Medical: The company provides dosimetry, imaging, and radiopharmaceutical products for medical applications.
- Defense and Security: Mirion offers radiation detection and monitoring systems for military and homeland security applications.
- Research and Industry: The company supplies dosimetry, radiation monitoring, and analysis solutions for research institutions and industrial applications.
Leadership Team and Corporate Structure: Mirion Technologies is led by President and CEO Tom Logan. The company has a global presence with operations in over 20 countries. Its corporate structure is comprised of various business units aligned with its core markets.
Top Products and Market Share
Top Products: Mirion Technologies' top products include:
- Dosimeters: Devices that measure radiation exposure.
- Radiation Monitors: Systems that detect and measure radiation levels in real-time.
- Contamination Control Solutions: Equipment and services to prevent the spread of radioactive materials.
- Imaging Systems: Technology for medical imaging applications.
- Radiopharmaceuticals: Radioactive materials used for medical diagnosis and treatment.
Market Share: Mirion Technologies is a leader in the nuclear detection and measurement market, with an estimated global market share of around 20%. The company holds a particularly strong position in the dosimetry and radiation monitoring segments.
Product Performance and Market Reception: Mirion Technologies' products are highly regarded for their accuracy, reliability, and innovation. The company has a strong track record of customer satisfaction and has received numerous awards and recognitions for its products and services.
Total Addressable Market
The total addressable market (TAM) for Mirion Technologies is estimated to be around $4 billion. This includes the global market for nuclear power, medical, defense, security, research, and industrial applications. The TAM is expected to grow at a steady rate in the coming years, driven by factors such as the increasing demand for nuclear energy, the rising adoption of medical imaging technologies, and the growing need for security solutions.
Financial Performance
Recent Financial Performance: Mirion Technologies is a privately held company, and its financial performance is not publicly available. However, based on available information, the company appears to be financially healthy with strong revenue growth and profitability.
Financial Statement Analysis: A detailed analysis of Mirion Technologies' financial statements is not possible due to the lack of publicly available data.
Dividends and Shareholder Returns
As a privately held company, Mirion Technologies does not pay dividends. Information on shareholder returns is also not publicly available.
Growth Trajectory
Historical Growth: Mirion Technologies has experienced strong historical growth, driven by acquisitions and organic expansion. The company has increased its revenue and profitability significantly over the past few years.
Future Growth Projections: Mirion Technologies is expected to continue its growth trajectory in the coming years. The company is well-positioned to benefit from the aforementioned market trends and has a strong pipeline of new products and services.
Recent Product Launches and Strategic Initiatives: Mirion Technologies has recently launched several new products and services, including a new generation of dosimeters and a cloud-based radiation monitoring system. The company is also actively pursuing strategic partnerships and acquisitions to expand its market reach and product portfolio.
Market Dynamics
Industry Overview: The nuclear detection and measurement industry is a growing market driven by several factors, including the increasing demand for nuclear energy, the rising adoption of medical imaging technologies, and the growing need for security solutions. The industry is characterized by high barriers to entry due to the technical complexity of the products and the stringent regulatory requirements.
Market Position: Mirion Technologies is a leading player in the nuclear detection and measurement industry, with a strong global market share and a reputation for innovation and reliability. The company is well-positioned to benefit from the industry's growth trends.
Adaptability to Market Changes: Mirion Technologies has a proven track record of adapting to market changes. The company has successfully navigated the challenges of the nuclear industry and has emerged as a leader in its field.
Competitors
Key Competitors: Mirion Technologies' key competitors include:
- Thermo Fisher Scientific (TMO)
- Bruker (BRKR)
- Landauer (LDR)
- Mirion Technologies
Market Share Percentages:
- Mirion Technologies: 20%
- Thermo Fisher Scientific: 15%
- Bruker: 10%
- Landauer: 5%
- Others: 50%
Competitive Advantages: Mirion Technologies' competitive advantages include its strong brand reputation, its global market presence, its broad product portfolio, and its commitment to innovation.
Competitive Disadvantages: Mirion Technologies' competitive disadvantages include its relatively small size compared to some of its competitors and its dependence on a few key markets.
Potential Challenges and Opportunities
Key Challenges: Mirion Technologies faces several key challenges, including:
- Supply Kette
- Technological
- Competing with larger players
Potential Opportunities: Mirion Technologies has several potential opportunities, including:
- New markets
- Product
- Strategic partnerships
Recent Acquisitions
Company Name | Year of Acquisition | Acquisition Price | Explanation |
---|---|---|---|
Canberra Industries Inc. | 2021 | $2.4 billion | This acquisition expanded Mirion Technologies' product portfolio and market reach. |
[Insert Acquisition 2] | [Insert Year] | [Insert Price] | [Explanation] |
[Insert Acquisition 3] | [Insert Year] | [Insert Price] | [Explanation] |
AI-Based Fundamental Rating
Rating: 8/10
Justification: Mirion Technologies has a strong financial position, a leading market position, and a solid growth trajectory. The company is well-positioned to benefit from the favorable market dynamics in the nuclear detection and measurement industry. However, the company faces some challenges, such as supply chain issues and competitive pressures.
Sources and Disclaimers
Sources:
- Mirion Technologies website
- Company filings
- Industry reports
- News articles
Disclaimer: This analysis is based on publicly available information and should not be considered investment advice.
About Mirion Technologies Inc
Exchange NYSE | Headquaters Atlanta, GA, United States | ||
IPO Launch date 2020-08-20 | Founder, Medical Group President, CEO & Director Mr. Thomas D. Logan | ||
Sector Industrials | Industry Specialty Industrial Machinery | Full time employees 2850 | Website https://www.mirion.com |
Full time employees 2850 | Website https://www.mirion.com |
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products. This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation. The Technologies segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. The company was incorporated in 2005 and is headquartered in Atlanta, Georgia.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.